ARTAN Bio
PrivateLast Round
Seed
Jun 4, 2026
Total Funding Raised
$291,300
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ARTAN Bio is a biotechnology company developing a novel engineered suppressor tRNA system to address genetic and age-related diseases caused by nonsense mutations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, DAOs, Tokenization
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ARTAN Bio Comparables
Compare ARTAN Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tevard Biosciences | 88% | |
| Alltrna | 86% | |
| Codone Biotechnology | 85% |
ARTAN Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 4, 2026 | ||||
| Pre Seed | Aug 2, 2023 |
ARTAN Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| VitaDAO | Pre Seed, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 4, 2026
$200K round with participation from VitaDAO.
ARTAN Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ARTAN Bio's valuation, stock price, and market status.
Is ARTAN Bio a public or private company?
ARTAN Bio is a private company.
What is the current stock price of ARTAN Bio?
ARTAN Bio is a private company with no public stock price. No recent secondary market data is available.
How much is ARTAN Bio worth (valuation)?
Valuation information for ARTAN Bio is not publicly available.
Can I buy ARTAN Bio stock?
ARTAN Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ARTAN Bio's last funding round?
ARTAN Bio's most recent funding round was Seed on July 1, 2026.
Who are the main investors in ARTAN Bio?
Key investors in ARTAN Bio include VitaDAO.
Will ARTAN Bio IPO soon?
No public IPO plans have been announced for ARTAN Bio.
How can I track ARTAN Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ARTAN Bio's secondary market activity and sign up for updates.